95 related articles for article (PubMed ID: 9036391)
1. [Binding of epirubicin to human plasma protein and erythrocytes: interaction with the cytoprotective amifostine].
Pernkopf I; Tesch G; Dempe K; Kletzl H; Schüller J; Czejka M
Pharmazie; 1996 Nov; 51(11):897-901. PubMed ID: 9036391
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo binding of epirubicin to red blood cells and human plasma proteins.
Bandak S; Czejka M; Schüller J
Z Naturforsch C J Biosci; 1994; 49(7-8):483-8. PubMed ID: 7945673
[TBL] [Abstract][Full Text] [Related]
3. Partitioning of thioridazine and mesoridazine in human blood fractions.
Dinovo EC; Pollak H; Gottschalk LA
Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):143-6. PubMed ID: 6748818
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction between 4'-epidoxorubicin and the multidrug resistance reverting agent quinine.
Czejka M; Bandak S; Simon D; Schüller J; Weiss C; Schernhammer E
Z Naturforsch C J Biosci; 1995; 50(7-8):565-70. PubMed ID: 7546045
[TBL] [Abstract][Full Text] [Related]
5. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
[TBL] [Abstract][Full Text] [Related]
6. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
Plum A; Müller LK; Jansen JA
Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
[TBL] [Abstract][Full Text] [Related]
7. Hydroxylamine treatment increases glutathione-protein and protein-protein binding in human erythrocytes.
Spooren AA; Evelo CT
Blood Cells Mol Dis; 1997 Dec; 23(3):323-36. PubMed ID: 9398534
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic drug interaction between epirubicin and interferon-alpha-2b in serum and red blood cells.
Bandak S; Czejka M; Schüller J; Schernhammer E
Arzneimittelforschung; 1995 Feb; 45(2):212-5. PubMed ID: 7710452
[TBL] [Abstract][Full Text] [Related]
9. [Protein binding of fenpentadiol-14C (2-méthyl-4-p-chlorophényl-2,4-pentane-diol) in vivo and in vitro (author's transl)].
Dormard Y; Plessas C; Benakis A
J Pharmacol; 1982; 13(1):11-20. PubMed ID: 6175856
[TBL] [Abstract][Full Text] [Related]
10. In vitro binding of MX2 (KRN8602) and epirubicin to human plasma protein.
Zhang WZ; Cosolo W; Zalcberg J
Pharmacology; 1997 Dec; 55(6):279-84. PubMed ID: 9413856
[TBL] [Abstract][Full Text] [Related]
11. In vitro behaviour of sesquiterpene lactones and sesquiterpene lactone-containing plant preparations in human blood, plasma and human serum albumin solutions.
Wagner S; Kratz F; Merfort I
Planta Med; 2004 Mar; 70(3):227-33. PubMed ID: 15114499
[TBL] [Abstract][Full Text] [Related]
12. L-Cysteine influx and efflux: a possible role for red blood cells in regulation of redox status of the plasma.
Yildiz D; Uslu C; Cakir Y; Oztas H
Free Radic Res; 2006 May; 40(5):507-12. PubMed ID: 16551577
[TBL] [Abstract][Full Text] [Related]
13. A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery.
Yu S; Li S; Yang H; Lee F; Wu JT; Qian MG
Rapid Commun Mass Spectrom; 2005; 19(2):250-4. PubMed ID: 15609367
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma.
Kuo YM; Kokjohn TA; Kalback W; Luehrs D; Galasko DR; Chevallier N; Koo EH; Emmerling MR; Roher AE
Biochem Biophys Res Commun; 2000 Feb; 268(3):750-6. PubMed ID: 10679277
[TBL] [Abstract][Full Text] [Related]
15. Binding of colchicine and thiocolchicoside to human serum proteins and blood cells.
Sabouraud A; Chappey O; Dupin T; Scherrmann JM
Int J Clin Pharmacol Ther; 1994 Aug; 32(8):429-32. PubMed ID: 7981928
[TBL] [Abstract][Full Text] [Related]
16. [Disposition of fentanyl in human blood].
Lehmann KA; Schmitz KF; Daub D
Anaesthesist; 1983 Jul; 32(7):329-34. PubMed ID: 6614420
[TBL] [Abstract][Full Text] [Related]
17. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of methylmercury in blood of bottlenose dolphins (Tursiops truncatus).
Ancora S; Rossi R; Simplicio PD; Lusini L; Leonzio C
Arch Environ Contam Toxicol; 2002 Apr; 42(3):348-53. PubMed ID: 11910464
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of total, free and protein bound thiols as well as sulfane sulfur in different age groups of rats.
Iciek M; Chwatko G; Lorenc-Koci E; Bald E; Włodek L
Acta Biochim Pol; 2004; 51(3):815-24. PubMed ID: 15448741
[TBL] [Abstract][Full Text] [Related]
20. Contradistinction between doxorubicin and epirubicin: in-vitro interaction with blood components.
Ramanathan-Girish S; Boroujerdi M
J Pharm Pharmacol; 2001 Jun; 53(6):815-21. PubMed ID: 11428657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
